The Johnson & Johnson Tylenol Controversies |
ICMR HOME | ICMR Case Study Collection
» Business Ethics Case Studies » ICMR Case Study Collection » ICMR Home » Mini Case Studies » Micro Case Studies » View Detailed Pricing Info » How To Order This Case » Business Case Studies
Please note: |
|||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract:
Though the company received bad publicity and had to spend millions of dollars in legal settlements, J&J was reluctant to have more explicit warnings on Tylenol's labels. This was in contrast to the company's response in the previous product tampering crises. However, in 1997, following the the FDA labeling rules, J&J made many changes in Tylenol's labels. Issues:» Ethical issues involved in the overdose controversy and discuss the right approach to resolving the crisis in right, proper and just way Contents:
Keywords:J&J, Tylenol, acetaminophen-based analgesic, OTC drug,leader,1982, Cyanide, six months, Tylenol, medical practitioners, side-effects, bad publicity, millions, dollars, legal settlements,1997, FDA labeling rules The Johnson & Johnson Tylenol Controversies - Next Page>>
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Case Studies Links:-
Case Studies,
Mini Case Studies,
Micro Case Studies,
Simplified Case Studies.
Other Case Studies:-
Multimedia Case Studies,
Cases in Other Languages.
Business Reports Link:-
Business Reports.
Books:-
Text Books,
Work Books,
Case Volumes.